Our finding that these focal deletions occur in tumors with larger chromosome 19 amplifications further supports the hypothesis that BRD4 focal deletions serve as a mechanism to fine-tune gene expression, rather than alter a tumor suppressor gene, and is more often observed with recurrent deletions. This evidence concerns the gene BRD4 and neoplasm.